← Cancer Treatment and Research Communications
Papers in Cancer Treatment and Research Communications
Page 3 · newest first
- Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancerCancer Treatment and Research Communications · 2026
- Cancer treatment-related risk factors for stroke among patients with lung cancer: A systematic review and meta-analysisCancer Treatment and Research Communications · 2026
- A Pan-Cancer Portrait of PDK1: From Oncogenic Driver to Context-Dependent Immunological RegulatorCancer Treatment and Research Communications · 2026
- The Evolving Role of Physiotherapy in Oncology Rehabilitation: An Evidence-Based Review Addressing Scope, Efficacy, Equity, and Educational ImperativesCancer Treatment and Research Communications · 2026
- Systematic literature review of secondary primary malignancies related to a CAR-T treatment in patients with multiple myeloma, lymphoma or leukemiaCancer Treatment and Research Communications · 2026
- Non-Coding RNAs at the Intersection of Interferon Signaling and Cancer: Mechanistic Insights and Clinical ProspectsCancer Treatment and Research Communications · 2026
- Assessment of Bacterial Infection Risk Factors and Related Complications in Newly Diagnosed Multiple Myeloma: A Retrospective Cohort AnalysisCancer Treatment and Research Communications · 2026
- Assessing the Correlation Between CD15 Expression and Gleason Score and Grade Groups in Prostate Adenocarcinoma: A Cross-Sectional StudyCancer Treatment and Research Communications · 2026
- Preliminary evaluation of Chidamide in combination with novel [177Lu]Lu-DOTAGA-Rituximab in Rituximab-resistant Raji cellsCancer Treatment and Research Communications · 2026
- HDAC4 overexpression predicts aggressive phenotypes and poor outcomes in urothelial carcinomaCancer Treatment and Research Communications · 2026
- Reference materials and External Quality Assessment for Liquid Biopsy assays: Expert Opinions from the European Liquid Biopsy Society ctDNA WorkshopCancer Treatment and Research Communications · 2026
- Emerging Light-Based Strategies in Cancer Theranostics: Photodynamic Therapy, Nanomedicine, and Precision OncologyCancer Treatment and Research Communications · 2026
- Durable Clinical Benefit and Progression-Free Survival in Patients with PD-L1 ≥50% NSCLC Receiving Pembrolizumab: Impact of Nutritional and Inflammatory MarkersCancer Treatment and Research Communications · 2026
- Exploring Knowledge, Attitudes, and Practices on Cervical Cancer Screening and Their Associated Factors among Female University Students at Debre Markos University, EthiopiaCancer Treatment and Research Communications · 2026
- Metabolic Signatures and Predictive Biomarkers of Liposomal Doxorubicin-Induced Hypersensitivity in Breast Cancer: A Pilot StudyCancer Treatment and Research Communications · 2026
- Precision oncology in Bulgaria: a prospective study of metastatic colorectal cancer patientsCancer Treatment and Research Communications · 2026
- Artificial intelligence in oral oncology: Current advances and future potential in diagnosis, prognosis, and therapeutic decision-makingCancer Treatment and Research Communications · 2026
- Microvessel density as a prognostic factor in renal cell carcinoma: A systematic review and meta-analysis with individual patient data reconstructed from previous Kaplan‒Meier curvesCancer Treatment and Research Communications · 2026
- A predictive nomogram for cancer-specific survival in elderly patients with ductal carcinoma in situ after lumpectomy: A SEER-based retrospective studyCancer Treatment and Research Communications · 2026
- BRAF mutation predicts survival after immunotherapy across multiple cancer typesCancer Treatment and Research Communications · 2026
- Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitorsCancer Treatment and Research Communications · 2026
- An attention-guided residual 3D U-net with focal Tversky–Dice loss for multi-modal pancreatic tumor segmentation using synthetic volumetric imagingCancer Treatment and Research Communications · 2026
- The association between parity, age of first full term pregnancy and invasive lobular breast cancer: a case-only analysisCancer Treatment and Research Communications · 2026
- Knowledge, attitude, and practice of healthcare professionals towards the prevention of Marjolin’s ulcer in an African suburban tertiary care institution: A cross-sectional studyCancer Treatment and Research Communications · 2026
- Treatment landscape, outcomes, and healthcare resource utilization in FLT3+ relapsed/refractory acute myeloid leukemia in MexicoCancer Treatment and Research Communications · 2026
- RHOXF1/TSGA10 axis: a possible molecular mechanism of carcinogenesisCancer Treatment and Research Communications · 2026
- Multimodal liquid biopsy surveillance after pancreatectomy for pancreatic ductal adenocarcinoma: evidence and a confirmation‑gated, trial‑ready frameworkCancer Treatment and Research Communications · 2026
- Integrative multi-omics and machine learning/deep learning approaches in cancer knowledge discovery: A scoping reviewCancer Treatment and Research Communications · 2026
- Synergistic cytotoxic effect of doxorubicin and bortezomib on lung cancer cell lines using 2D and 3D modelsCancer Treatment and Research Communications · 2026
- Malaria driven mechanisms shaping cancer risk and aggressiveness in African populationsCancer Treatment and Research Communications · 2026
- Transcriptomic landscape of coexisting ovarian clear cell carcinoma and endometriosis: Insights into malignant transformationCancer Treatment and Research Communications · 2026
- Colorectal cancer trends in Iran: An age-period-cohort analysis of incidence and mortality and trends in key risk factorsCancer Treatment and Research Communications · 2026
- Chemotherapy-induced liver injury in Tibetan breast cancer patients: clinical features and risk factor analysisCancer Treatment and Research Communications · 2026
- Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancerCancer Treatment and Research Communications · 2026
- Development and pilot feasibility of Kit-CAT, a serious-game-supported consultation for discussing complementary and alternative therapies in breast cancer careCancer Treatment and Research Communications · 2026
- Harnessing tumor-agnostic biomarkers for precision medicine in lymphomaCancer Treatment and Research Communications · 2026
- Survival outcomes in EGFR-mutant versus wild-type locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy alone in the pre-PACIFIC/LAURA trial era: A systematic review and meta-analysis using reconstructed individual patient dataCancer Treatment and Research Communications · 2026
- Clinical significance of immunocyte- and ferroptosis-related markers for the prognosis of patients with tenosynovial giant cell tumor: A cross-sectional studyCancer Treatment and Research Communications · 2026
- Cholesteryl ester and cholesterol as candidate biomarkers for differentiating primary lung squamous cell carcinoma from head and neck squamous cell carcinoma; proof-of-concept biomarker studyCancer Treatment and Research Communications · 2026
- Dual-jet transition cold atmospheric plasma suppresses colon cancer stem cells via matrix metalloproteinase regulationCancer Treatment and Research Communications · 2026
- The microbiome–epigenome axis: Regulation of host genome function across development and diseaseCancer Treatment and Research Communications · 2026
- Immune Checkpoint Inhibitor Outcomes Across Child-Pugh A, B, and C Hepatocellular Carcinoma: A Real-World Integrated Health-System CohortCancer Treatment and Research Communications · 2026
- Assessment of national cancer care network guideline-adherent treatment differences as a contributor to racial disparities in epithelial and non-epithelial ovarian cancer survivalCancer Treatment and Research Communications · 2026
- Immunogenic effects of hyperthermia in an experimental model of peritoneal metastases of colorectal cancer enhance tumor susceptibility to immunotherapyCancer Treatment and Research Communications · 2026
- Second primary malignancies after stereotactic body radiotherapy vs surgery for early-stage lung cancer: a U.S. population-based study, 2010-2015Cancer Treatment and Research Communications · 2026
- Tolvaptan for paraneoplastic SIADH in small cell lung cancer: a scoping reviewCancer Treatment and Research Communications · 2026
- Prevalence of cancer-related fatigue after treatment in patients with non-metastatic gastrointestinal cancersCancer Treatment and Research Communications · 2026
- Lenvatinib plus pembrolizumab for advanced or recurrent endometrial cancer: a retrospective multi-institutional survey in the Kinki district of JapanCancer Treatment and Research Communications · 2026
- Natural and in vitro-generated regulatory T-cell subsets differentially modulate phenotype and drug response in K562 leukemic cellsCancer Treatment and Research Communications · 2026
- The eco-evolutionary dynamics of acute myeloid leukemia: From clonal games to clinical interventionCancer Treatment and Research Communications · 2026